Non-invasive limb ischemic pre-conditioning reduces oxidative stress and attenuates myocardium ischemia-reperfusion injury in diabetic rats

Free Radical Research

Volumn 45, Issue 2, 2011, Pages 201-210

  Zhu, Xue Hui ^a,b   Yuan, Heng Jie ^a   Wu, Yan Na ^a   Kang, Yi ^a   Jiao, Jian Jie ^a   Gao, Wei Zhen ^a   Liu, Yan Xia ^a   Lou, Jian Shi ^a   Xia, Zhengyuan ^c  

^a Tianjin Research Center of Basic Medical Science   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetic; Oxidative stress; Repeated non invasive limb ischemic pre conditioning

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; ISCHEMIC PRECONDITIONING; LIMB ISCHEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; STREPTOZOCIN DIABETES;

ANIMALS; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; EXTREMITIES; GENE EXPRESSION; GLUTATHIONE PEROXIDASE; HEMODYNAMICS; ISCHEMIC PRECONDITIONING; MALE; MALONDIALDEHYDE; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

RATTUS;

EID: 78651321298     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2010.522576     Document Type: Review

References (43)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
2. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87:893-899.
3. Diwan V, Kant R, Jaggi AS, Singh N, Singh D. Signal mechanism activated by erythropoietin preconditioning and remote renal preconditioning-induced cardioprotection. Mol Cell Biochem 2008;315:195-201.
4. ATP channel. Cardiovasc Res 2002;55:576-582.
5. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Reding-ton AN, MacAllister R. Transient limb ischemia induces remote ischemic preconditioning in vivo . Circulation 2002;106:2881-2883.
6. Oxman T, Arad M, Klein R, Avazov N, Rabinowitz B. Limb ischemia preconditions the heart against reperfusion tachyar-rhythmia. Am J Physiol 1997;273:H1707-H1712.
7. Li SJ, Wu YN, Kang Y, Yin YQ, Gao WZ, Liu YX, Lou JS. Noninvasive limb ischemic preconditioning protects against myocardial I/R injury in rats. J Surg Res 2009;.
8. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007;59:418-458.
9. AI'P channel dysfunction. Mol Cell Biochem 2003;249:21-30.
10. Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 2007;292:920-926.
11. Ghosh S, Standen NB, Gali ñ ianes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001;37:711-718.
12. Tanaka K, Kehl F, Gu W, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 2002;282:H2018-H2023.
13. Galagudza MM, Nekrasova MK, Syrenskii AV, Nifontov EM. Resistance of the myocardium to ischemia and the effi cacy of ischemic preconditioning in experimental Diabetes Mellitus. Neurosci Behav Physiol 2007;37:489-493.
14. Ravingerová T, Stetka R, Pancza D, Ulicn á O, Ziegelh ö ffer A, Styk J. Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart. Physiol Res 2000;49:607-616.
15. Tosaki A, Engelman DT, Engelman RM, Das DK. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 1996;31:526-536.
16. Zucchi R, Ghelardoni S, Evangelista S. Biochemical basis of ischemic heart injury and of cardioprotective interventions. Curr Med Chem 2007;14:1619-1637.
17. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in " stunned " myocardium of intact dogs with the use of the spin trap a- phenyl- N -tertbutyl nitrone. J Clin Invest 1988;82: 476-485.
18. M ü nzel T, Sinning C, Post F, Warnholtz A, Schulz E. Patho-physiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 2008;40:180-196.
19. Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury- review. J Surg Res 2008;150:304-330.
20. Ambros JT, Herrero-Fresneda I, Borau OG, Boira JM. Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int 2007;20:219-229.
21. Ma XJ, Zhang XH, Luo M, Li CM, Shao JH. Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction. Zhonghua Yi Xue Za Zhi 2007;87:114-117.
22. Pan YX, Ren AJ, Zheng J, Rong WF, Chen H, Yan XH, Wu C, Yuan WJ, Lin L. Delayed cytoprotection induced by hypoxic preconditioning in cultured neonatal rat cardiomyocytes: role of GRP78. Life Sci 2007;81:1042-1049.
23. Duda M, Konior A, Klemenska E, Beresewicz A. Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart. J Mol Cell Cardiol 2007;42:400-410.
24. Das DK, Prasad MR, Lu D, Jones RM. Preconditioning of heart by repeated stunning. Adaptive modifi cation of antioxi-dative defense system. Cell Mol Biol (Noisy-le-grand) 1992; 8:739-749.
25. Das DK, Maulik N. Cardiac genomic response following preconditioning stimulus. Cardiovasc Res 2006;70:254-263.
26. Yamashita N, Nishida M, Hoshida S, Kuzuya T, Hori M, Taniguchi N, Kamada T, Tada M. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 1994;94:2193-2199.
27. Chiueh CC, Andoh T, Chock PB. Induction of thioredoxin and mitochondrial survival proteins mediates precondition-ing-induced cardioprotection and neuroprotection. Ann N Y Acad Sci 2005;1042:403-418.
28. Zhou W, Zeng D, Chen R, Liu J, Yang G, Liu P, Zhou X. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol 2010; 31:22-29.
29. Chen YS, Chien CT, Ma MC, Tseng YZ, Lin FY, Wang SS, Chen CF. Protection ' outside the box ' (skeletal remote preconditioning) in rat model is triggered by free radical pathway. J Surg Res 2005;126:92-101.
30. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996;94:2193-2200.
31. Konstantinov IE, Li J, Cheung MM, Shimizu M, Stokoe J, Kharbanda RK, Redington AN. Remote ischemic preconditioning of the recipient reduces myocardial is chemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation 2005;79: 1691-1695.
32. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V, Downey GP, Liu PP, Cukerman E, Coles JG, Redington AN. The remote ischemic preconditioning stimulus modifi es inflammatory gene expression in humans. Phys-iol Genomics 2004;19:143-150.
33. Konstantinov IE, Arab S, Li J, Coles JG, Boscarino C, Mori A, et al. The remote ischemic preconditioning stimulus modifi es gene expression in mouse myocardium. J Thorac Cardiovasc Surg 2005;130:1326-1332. (Pubitemid 41543201)
34. Peralta C, Fernández L, Panés J, Prats N, Sans M, Piqué JM, Gelpí E, Roselló-Catafau J. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001;33:100-113.
35. Hausenloy DJ, Yellon DM. Preconditioning and postcondi-tioning: united at reperfusion. Pharmacol Ther 2007;116: 173-191.
36. Heidbreder M, Naumann A, Tempel K, Dominiak P, Dendorfer A. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Cardiovasc Res 2008;78:108-115.
37. Sivaraman V, Hausenloy DJ, Wynne AM, Yellon DM. Preconditioning the diabetic human myocardium. J Cell Mol Med 2010;14:1740-1746.
38. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of akt phosphorylation. Diabetes 2005;54:2360-2364.
39. Hotta H, Miura T, Miki T, Togashi N, Maeda T, Kim SJ, Tanno M, Yano T, Kuno A, Itoh T, Satoh T, Terashima Y, Ishikawa S, Shimamoto K. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts. Circ Res 2010;106:129-132.
40. Gross ER, Hsu AK, Gross GJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3 β . Diabetes 2007;56:127-136.
41. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006;47:2277-2282.
42. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. Lancet 2007;370:575-579.
43. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP, Gaunt ME. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007; 116:I98-I105.